These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9158194)

  • 21. Update on endocrine therapy for breast cancer.
    Buzdar AU; Hortobagyi G
    Clin Cancer Res; 1998 Mar; 4(3):527-34. PubMed ID: 9533518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New endocrine approaches in the treatment of breast cancer.
    von Minckwitz G; Kaufmann M
    Biomed Pharmacother; 1998; 52(3):122-32. PubMed ID: 9755805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine therapies of breast cancer.
    Goldhirsch A; Gelber RD
    Semin Oncol; 1996 Aug; 23(4):494-505. PubMed ID: 8757275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrine therapy for advanced or recurrent breast cancer].
    Sonoo H; Kurebayashi J
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):909-16. PubMed ID: 11478139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current status of adjuvant endocrine therapy for hormone responsive breast cancer].
    Ikeda T; Jinno H; Masamura S; Matsui A; Tajima G; Hohjoh T; Tokura H; Mitsui Y; Asaga S; Muto T; Fujiwara K; Kitajima M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):902-8. PubMed ID: 11478138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action and counter-action of hormones in human ovarian cancer.
    Roa BR; Slotman BJ
    Anticancer Res; 1989; 9(4):1005-7. PubMed ID: 2683984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination endocrine therapy in the management of breast cancer.
    Michaud LB; Jones KL; Buzdar AU
    Oncologist; 2001; 6(6):538-46. PubMed ID: 11743215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
    De Marchi T; Foekens JA; Umar A; Martens JW
    Drug Discov Today; 2016 Jul; 21(7):1181-8. PubMed ID: 27233379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The link between female infertility and cancer: epidemiology and possible aetiologies.
    Meirow D; Schenker JG
    Hum Reprod Update; 1996; 2(1):63-75. PubMed ID: 9079404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological roles of estrogen and progesterone in human endometrial carcinoma--new developments in potential endocrine therapy for endometrial cancer.
    Ito K; Utsunomiya H; Yaegashi N; Sasano H
    Endocr J; 2007 Dec; 54(5):667-79. PubMed ID: 17785917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.
    Salehi F; Dunfield L; Phillips KP; Krewski D; Vanderhyden BC
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):301-21. PubMed ID: 18368558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal therapy for breast cancer. An update.
    Gradishar WJ; Jordan VC
    Hematol Oncol Clin North Am; 1999 Apr; 13(2):435-55, vii. PubMed ID: 10363139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aromatase inhibitors and breast cancer.
    Miller WR
    Cancer Treat Rev; 1997 May; 23(3):171-87. PubMed ID: 9251721
    [No Abstract]   [Full Text] [Related]  

  • 35. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal therapy in ovarian cancer.
    Zheng H; Kavanagh JJ; Hu W; Liao Q; Fu S
    Int J Gynecol Cancer; 2007; 17(2):325-38. PubMed ID: 17362310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological and experimental data.
    Gadducci A; Cosio S; Gargini A; Genazzani AR
    Gynecol Endocrinol; 2004 Oct; 19(4):216-28. PubMed ID: 15724805
    [No Abstract]   [Full Text] [Related]  

  • 38. Estrogen, progesterone and epithelial ovarian cancer.
    Ho SM
    Reprod Biol Endocrinol; 2003 Oct; 1():73. PubMed ID: 14577831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aromatase inhibitors for breast cancer: pharmacoeconomic considerations.
    Higa GM
    Expert Opin Pharmacother; 2001 Jun; 2(6):987-95. PubMed ID: 11585014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen ("Nolvadex"): a review.
    Clemons M; Danson S; Howell A
    Cancer Treat Rev; 2002 Aug; 28(4):165-80. PubMed ID: 12363457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.